TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a report published on Friday. The brokerage issued a hold rating on the stock.

TherapeuticsMD Trading Up 4.3 %

Shares of NASDAQ:TXMD opened at $1.46 on Friday. The stock has a 50-day simple moving average of $1.01 and a 200-day simple moving average of $1.14. TherapeuticsMD has a 1 year low of $0.70 and a 1 year high of $2.44.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.